19-38506683-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000540.3(RYR1):​c.8692+137T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.277 in 1,474,534 control chromosomes in the GnomAD database, including 60,376 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.33 ( 8631 hom., cov: 31)
Exomes 𝑓: 0.27 ( 51745 hom. )

Consequence

RYR1
NM_000540.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.994

Publications

6 publications found
Variant links:
Genes affected
RYR1 (HGNC:10483): (ryanodine receptor 1) This gene encodes a ryanodine receptor found in skeletal muscle. The encoded protein functions as a calcium release channel in the sarcoplasmic reticulum but also serves to connect the sarcoplasmic reticulum and transverse tubule. Mutations in this gene are associated with malignant hyperthermia susceptibility, central core disease, and minicore myopathy with external ophthalmoplegia. Alternatively spliced transcripts encoding different isoforms have been described. [provided by RefSeq, Jul 2008]
RYR1 Gene-Disease associations (from GenCC):
  • malignant hyperthermia, susceptibility to, 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Genomics England PanelApp, Ambry Genetics
  • congenital multicore myopathy with external ophthalmoplegia
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Genomics England PanelApp
  • RYR1-related myopathy
    Inheritance: AR, AD Classification: DEFINITIVE Submitted by: ClinGen
  • central core myopathy
    Inheritance: AD, AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp
  • King-Denborough syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • malignant hyperthermia of anesthesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • autosomal recessive centronuclear myopathy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • benign Samaritan congenital myopathy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • congenital myopathy with myasthenic-like onset
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • lethal multiple pterygium syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 19-38506683-T-C is Benign according to our data. Variant chr19-38506683-T-C is described in ClinVar as Benign. ClinVar VariationId is 590617.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.445 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RYR1NM_000540.3 linkc.8692+137T>C intron_variant Intron 56 of 105 ENST00000359596.8 NP_000531.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RYR1ENST00000359596.8 linkc.8692+137T>C intron_variant Intron 56 of 105 5 NM_000540.3 ENSP00000352608.2

Frequencies

GnomAD3 genomes
AF:
0.326
AC:
49473
AN:
151858
Hom.:
8595
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.430
Gnomad AMI
AF:
0.260
Gnomad AMR
AF:
0.355
Gnomad ASJ
AF:
0.257
Gnomad EAS
AF:
0.363
Gnomad SAS
AF:
0.460
Gnomad FIN
AF:
0.289
Gnomad MID
AF:
0.316
Gnomad NFE
AF:
0.253
Gnomad OTH
AF:
0.333
GnomAD4 exome
AF:
0.271
AC:
358585
AN:
1322558
Hom.:
51745
Cov.:
21
AF XY:
0.276
AC XY:
182048
AN XY:
659430
show subpopulations
African (AFR)
AF:
0.428
AC:
12949
AN:
30282
American (AMR)
AF:
0.380
AC:
14075
AN:
37020
Ashkenazi Jewish (ASJ)
AF:
0.250
AC:
6214
AN:
24824
East Asian (EAS)
AF:
0.334
AC:
12421
AN:
37204
South Asian (SAS)
AF:
0.444
AC:
35513
AN:
79946
European-Finnish (FIN)
AF:
0.289
AC:
14126
AN:
48942
Middle Eastern (MID)
AF:
0.334
AC:
1838
AN:
5496
European-Non Finnish (NFE)
AF:
0.245
AC:
245274
AN:
1003146
Other (OTH)
AF:
0.290
AC:
16175
AN:
55698
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
11484
22967
34451
45934
57418
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
8294
16588
24882
33176
41470
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.326
AC:
49570
AN:
151976
Hom.:
8631
Cov.:
31
AF XY:
0.333
AC XY:
24768
AN XY:
74290
show subpopulations
African (AFR)
AF:
0.431
AC:
17864
AN:
41438
American (AMR)
AF:
0.355
AC:
5419
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
0.257
AC:
891
AN:
3468
East Asian (EAS)
AF:
0.362
AC:
1863
AN:
5144
South Asian (SAS)
AF:
0.461
AC:
2218
AN:
4814
European-Finnish (FIN)
AF:
0.289
AC:
3049
AN:
10566
Middle Eastern (MID)
AF:
0.313
AC:
92
AN:
294
European-Non Finnish (NFE)
AF:
0.253
AC:
17223
AN:
67958
Other (OTH)
AF:
0.338
AC:
714
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1651
3302
4954
6605
8256
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
490
980
1470
1960
2450
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.171
Hom.:
349
Bravo
AF:
0.333
Asia WGS
AF:
0.488
AC:
1694
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jun 14, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
Apr 03, 2018
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.87
CADD
Benign
5.4
DANN
Benign
0.72
PhyloP100
-0.99
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.060
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2915957; hg19: chr19-38997323; COSMIC: COSV62092643; COSMIC: COSV62092643; API